Show simple item record

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

dc.contributor.authorBruhn, Hanne
dc.contributor.authorAnderson, Annie S.
dc.contributor.authorHickman, Amy
dc.contributor.authorMacaskill, E. Jane
dc.contributor.authorTreweek, Shaun
dc.date.accessioned2021-06-07T13:58:01Z
dc.date.available2021-06-07T13:58:01Z
dc.date.issued2021-06-05
dc.identifier.citationBruhn , H , Anderson , A S , Hickman , A , Macaskill , E J & Treweek , S 2021 , ' Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial” ' , Trials , vol. 22 , no. 1 , 381 . https://doi.org/10.1186/s13063-021-05340-3en
dc.identifier.issn1745-6215
dc.identifier.otherPURE: 194726132
dc.identifier.otherPURE UUID: 1e6e4989-cecd-4412-b371-e28fcab2029f
dc.identifier.otherRIS: urn:01533BB382B5B86422E91AB5EDFB7135
dc.identifier.otherRIS: Bruhn2021
dc.identifier.otherScopus: 85107203204
dc.identifier.urihttps://hdl.handle.net/2164/16642
dc.descriptionAcknowledgements We would like to thank our ActWELL participants who attended the events for their interest and enthusiasm in making the events a success. We would like to thank Susan MacAskill for giving us permission to use a quote from her email to us. We are also grateful to the technical support who got us through all events, Cormac Staunton (of stauntonmedia.ie). We would also like to acknowledge and thank Dr Katie Gillies and Dr Seonaidh Cotton for their contribution to the design of the evaluation survey. HSRU is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. This work was supported by The Scottish Government, grant number BC/ Screening/17/01.en
dc.format.extent5
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectRandomised trialsen
dc.subjectResearch transparencyen
dc.subjectResult disseminationen
dc.subjectTrial conducten
dc.subjectOnline eventsen
dc.subjectCOVID-19en
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectBC/ Screening/17/01en
dc.subject.lccRen
dc.titleLetter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Psychologyen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s13063-021-05340-3
dc.identifier.vol22en
dc.identifier.iss1en


Files in this item

Thumbnail
Name:
Bruhn_etal_TRIALS_Letter_On_Sh ...
Size:
495.4Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record